Articoli con mandati relativi all'accesso pubblico - Peter GibbsUlteriori informazioni
Non disponibili pubblicamente: 7
Controlla
MiRNA‐362‐3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer
LL Christensen, H Tobiasen, A Holm, T Schepeler, MS Ostenfeld, ...
International journal of cancer 133 (1), 67-78, 2013
Mandati: Danish Council for Independent Research, Danish National Advanced Technology …
Controlla
Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes
DS Williams, D Mouradov, RN Jorissen, MR Newman, E Amini, ...
Gut 68 (3), 465-474, 2019
Mandati: National Health and Medical Research Council, Australia
Controlla
Survival impact of the Australian national bowel cancer screening programme
S Ananda, H Wong, I Faragher, IT Jones, M Steele, S Kosmider, J Desai, ...
Internal medicine journal 46 (2), 166-171, 2016
Mandati: National Health and Medical Research Council, Australia
Controlla
Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil‐to‐lymphocyte ratio in patients with metastatic renal cell carcinoma
D Day, Y Kanjanapan, E Kwan, D Yip, N Lawrentschuk, ID Davis, ...
Internal medicine journal 46 (11), 1291-1297, 2016
Mandati: National Health and Medical Research Council, Australia
Controlla
Neoadjuvant chemoradiotherapy and tumor recurrence in patients with early T-stage cancer of the lower rectum
IP Hayes, E Milanzi, P Gibbs, JC Reece
Annals of Surgical Oncology 27, 1570-1579, 2020
Mandati: National Health and Medical Research Council, Australia
Controlla
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
L Gately, C Mesía, JM Sepúlveda, S Del Barco, E Pineda, R Gironés, ...
Journal of Neuro-Oncology 166 (3), 407-415, 2024
Mandati: Government of Spain
Controlla
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
J Tie, Y Wang, SN Lo, K Lahouel, JD Cohen, R Wong, JD Shapiro, ...
Nature Medicine, 1-10, 2025
Mandati: National Health and Medical Research Council, Australia
Disponibili pubblicamente: 109
Controlla
Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
Mandati: US National Institutes of Health, Wellcome Trust, Governo Italiano
Controlla
Detection and localization of surgically resectable cancers with a multi-analyte blood test
JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ...
Science 359 (6378), 926-930, 2018
Mandati: US Department of Defense, US National Institutes of Health, Howard Hughes …
Controlla
Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours
J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ...
The Journal of pathology 232 (2), 199-209, 2014
Mandati: US National Institutes of Health, National Institute of Health and Medical …
Controlla
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
J Tie, Y Wang, C Tomasetti, L Li, S Springer, I Kinde, N Silliman, M Tacey, ...
Science translational medicine 8 (346), 346ra92-346ra92, 2016
Mandati: US National Institutes of Health
Controlla
Cancer classification using the Immunoscore: a worldwide task force
J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ...
Journal of translational medicine 10, 1-10, 2012
Mandati: US National Institutes of Health
Controlla
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
B Tran, S Kopetz, J Tie, P Gibbs, ZQ Jiang, CH Lieu, A Agarwal, DM Maru, ...
Cancer 117 (20), 4623-4632, 2011
Mandati: US National Institutes of Health
Controlla
Effect of aspirin on all-cause mortality in the healthy elderly
JJ McNeil, MR Nelson, RL Woods, JE Lockery, R Wolfe, CM Reid, ...
New England Journal of Medicine 379 (16), 1519-1528, 2018
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
S Kopetz, J Desai, E Chan, JR Hecht, PJ O'Dwyer, D Maru, V Morris, ...
Journal of clinical oncology 33 (34), 4032-4038, 2015
Mandati: US National Institutes of Health
Controlla
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J Tie, I Kinde, Y Wang, HL Wong, J Roebert, M Christie, M Tacey, R Wong, ...
Annals of Oncology 26 (8), 1715-1722, 2015
Mandati: US National Institutes of Health
Controlla
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang, S Kosmider, R Wong, ...
New England Journal of Medicine 386 (24), 2261-2272, 2022
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised …
LA Diaz, KK Shiu, TW Kim, BV Jensen, LH Jensen, C Punt, D Smith, ...
The Lancet Oncology 23 (5), 659-670, 2022
Mandati: US National Institutes of Health, National Institute of Health and Medical …
Controlla
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
JD Cohen, AA Javed, C Thoburn, F Wong, J Tie, P Gibbs, CM Schmidt, ...
Proceedings of the National Academy of Sciences 114 (38), 10202-10207, 2017
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, National …
Controlla
Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer
J Tie, JD Cohen, Y Wang, M Christie, K Simons, M Lee, R Wong, ...
JAMA oncology 5 (12), 1710-1717, 2019
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software